blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4206222

EP4206222 - SIGNAL PEPTIDE FOR REDUCING END HETEROGENEITY OF HETEROLOGOUS POLYPEPTIDE [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  02.06.2023
Database last updated on 10.07.2024
FormerThe international publication has been made
Status updated on  05.03.2022
Most recent event   Tooltip14.03.2024Supplementary search reportpublished on 10.04.2024  [2024/15]
Applicant(s)For all designated states
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
No. 7 Kunlunshan Road
Economic and Technological Development Zone
Lianyungang, Jiangsu 222047 / CN
For all designated states
Shanghai Hengrui Pharmaceutical Co., Ltd.
No.279 Wenjing Road
Minhang District
Shanghai 200245 / CN
[2023/27]
Inventor(s)01 / ZHOU, Songtao
Shanghai 200245 / CN
02 / LIU, Xun
Shanghai 200245 / CN
 [2023/27]
Representative(s)Dragotti & Associati S.R.L., et al
Via Nino Bixio, 7
20129 Milano / IT
[N/P]
Former [2023/27]Sonzogni, Laura Gabriella, et al
Dragotti & Associati S.r.l.
Via Nino Bixio, 7
20129 Milano / IT
Application number, filing date21860507.927.08.2021
[2023/27]
WO2021CN114911
Priority number, dateCN20201088287328.08.2020         Original published format: CN202010882873
CN20211095812820.08.2021         Original published format: CN202110958128
[2023/27]
Filing languageZH
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2022042673
Date:03.03.2022
Language:ZH
[2022/09]
Type: A1 Application with search report 
No.:EP4206222
Date:05.07.2023
Language:EN
[2023/27]
Search report(s)International search report - published on:CN03.03.2022
(Supplementary) European search report - dispatched on:EP13.03.2024
ClassificationIPC:C07K16/00, C07K14/00, C12N15/00, A61K39/00, C12P21/08
[2023/27]
CPC:
C07K16/065 (EP); C07K16/283 (US); A61K39/00 (EP);
C07K14/00 (EP); C07K16/28 (EP,US); C07K16/30 (EP);
C07K16/32 (EP); C07K2317/14 (EP,US); C07K2317/24 (EP,US);
C07K2317/40 (EP); C07K2317/52 (EP); C07K2317/565 (US);
C07K2317/567 (US); C07K2317/732 (EP,US); C07K2317/77 (EP);
C07K2317/92 (EP,US); C07K2319/02 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/27]
TitleGerman:SIGNALPEPTID ZUR REDUZIERUNG DER HETEROGENITÄT DES ENDES EINES HETEROLOGEN POLYPEPTIDS[2023/27]
English:SIGNAL PEPTIDE FOR REDUCING END HETEROGENEITY OF HETEROLOGOUS POLYPEPTIDE[2023/27]
French:PEPTIDE SIGNAL POUR RÉDUIRE L'HÉTÉROGÉNÉITÉ FINALE D'UN POLYPEPTIDE HÉTÉROLOGUE[2023/27]
Entry into regional phase20.02.2023Translation filed 
20.02.2023National basic fee paid 
20.02.2023Search fee paid 
20.02.2023Designation fee(s) paid 
20.02.2023Examination fee paid 
Examination procedure20.02.2023Examination requested  [2023/27]
Fees paidRenewal fee
26.07.2023Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO03102017  (CENTOCOR INC [US]) [X] 1,2,4,6,7,10-12 * CNTO 4164;; sequence 9 *;
 [XY]WO2007143090  (AVEO PHARMACEUTICALS INC [US], et al) [X] 1,2,4,6,7,10-12 * paragraph [0148] - paragraph [0180]; table 2 * * clones 1D3, 3A3,1F3, 3A12; paragraph [0208]; figure 4 * * clones 2P8 and 3B6;; figure 2 * [Y] 1-15;
 [Y]US2015225482  (SONG ZHIWEI [SG]) [Y] 1-15 * abstract *;
 [Y]  - HARYADI RYAN ET AL, "Optimization of Heavy Chain and Light Chain Signal Peptides for High Level Expression of Therapeutic Antibodies in CHO Cells", PLOS ONE, US, (20150201), vol. 10, no. 2, doi:10.1371/journal.pone.0116878, ISSN 1932-6203, page e0116878, XP093133740 [Y] 1-15 * abstract *

DOI:   http://dx.doi.org/10.1371/journal.pone.0116878
 [Y]  - GIBSON S J ET AL, "N-terminal or signal peptide sequence engineering prevents truncation of human monoclonal antibody light chains", BIOTECHNOLOGY AND BIOENGINEERING, JOHN WILEY, HOBOKEN, USA, (20170508), vol. 114, no. 9, doi:10.1002/BIT.26301, ISSN 0006-3592, pages 1970 - 1977, XP071115450 [Y] 1-15 * abstract *

DOI:   http://dx.doi.org/10.1002/bit.26301
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.